{"id":255,"date":"2021-09-19T13:11:01","date_gmt":"2021-09-19T13:11:01","guid":{"rendered":"https:\/\/test.lab.cor2ed.com\/cms\/experts\/prof-frederic-bibeau\/"},"modified":"2023-09-06T18:16:51","modified_gmt":"2023-09-06T16:16:51","slug":"prof-frederic-bibeau","status":"publish","type":"experts","link":"https:\/\/test.lab.cor2ed.com\/cms\/experts\/prof-frederic-bibeau\/","title":{"rendered":"Prof. Fr\u00e9d\u00e9ric Bibeau"},"content":{"rendered":"<p>Fr\u00e9d\u00e9ric Bibeau, MD, PhD, is a Professor of Pathology at the head of the Pathology Department of the Besan\u00e7on University Hospital, Franche-Comt\u00e9 University. He is involved in translational research, in immuno-oncology of solid tumors and in gastrointestinal tumor pathology, notably colorectal cancer, both at the diagnostic and research levels. He is\u00a0responsible for several long courses in pathology and molecular pathology, notably\u00a0of the GI tract. Since ten years his work has been focused on rectal cancer, microsatellite unstable colorectal cancer, liver metastases after induction treatment, peritoneal carcinomatosis and predictive factors linked to targeted therapies and immunotherapy. He also involved in national and international groups specialized in rare tumors of the peritoneum. He was one of two coordinators of the BIG-RENAPE network, corresponding to a biological and clinical database dedicated to peritoneal carcinomatosis of digestive origin.<\/p>\n<p>Professor Bibeau is author or co-author of 213 publications. He belongs to the board of national and international journals. He is a member of the French Society of Pathology, the International Academy of Pathology, the French Federation of Digestive Oncology (FFCD). He has been an active member of the European Society of Medical Oncology (ESMO) and the ESMO-Precision-Medicine working group.<\/p>\n","protected":false},"author":{"id":1,"first_name":"Francisco","nickname":"Superadmin","email":"jose.santos@cor2ed.com"},"featured_media":170002,"menu_order":255,"template":"","groups":[24],"class_list":["post-255","experts","type-experts","status-publish","has-post-thumbnail","hentry","groups-members"],"expert_info_prefix":"Prof.","expert_info_first-name":"Fr\u00e9d\u00e9ric","expert_info_last-name":"Bibeau","expert_info_institution":"Besan\u00e7on University Hospital","expert_info_country":"FR","expert_info_specialization":"Pathologist","expert_info_map-code":"eu_150","expert_info_disclosures":"<p>Amgen, MSD and Sanofi.\u00a0<\/p>\r\n<p>&nbsp;<\/p>","expert_info_linkedin":"","expert_info_twitter":"","expert_info_instagram":"","expert_info_facebook":"","_links":{"self":[{"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/experts\/255","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/experts"}],"about":[{"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/types\/experts"}],"version-history":[{"count":4,"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/experts\/255\/revisions"}],"predecessor-version":[{"id":170115,"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/experts\/255\/revisions\/170115"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/media\/170002"}],"wp:attachment":[{"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/media?parent=255"}],"wp:term":[{"taxonomy":"groups","embeddable":true,"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/groups?post=255"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}